Shopping Cart 0
Cart Subtotal
USD 0

Central Nervous System Drugs Global Market Forecast To 2022

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 8000

Details

North America was the largest region in the global central nervous system drugs market, accounting for 43% of the market in 2018. Asia Pacific was the second largest region accounting for 24% of the global central nervous system drugs market. Africa was the smallest region in the global central nervous system drugs market.

Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson's disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%. For instance, in 2017, Michael J. Fox Foundation for Parkinson's Research collaborated with specialty drugmaker Cynapsus Therapeutics and Intel to integrate wearable technology in a Phase-III clinical trial of APL-130277, an experimental drug for Parkinson's disease. Biogen, a leading CNS drugmaker is using Fitbit, a smart wearable tracker, to better understand multiple sclerosis in patient studies, and the technology is expected to extend in Alzheimer's disease research.

READ MORE

Table Of Content

Scope

1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Central Nervous System Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth

8.1. Market Size

8.2. Historic Market Growth, Value (USD Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value (USD Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis

9.1. Global Central Nervous System Drugs Market, 2018, By Region, Value (USD Billion)

9.2. Global Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Region

9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation

10.1. Global Central Nervous System Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

10.1.1. Nervous System Drugs

10.1.2. Analgesics

10.1.3. Anti-Parkinson drugs

10.1.4. Anesthetics

10.1.5. Anti-Epileptics

10.1.6. Other CNS drugs

11. Central Nervous System Drugs Market Metrics

11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2014-2022, Global

11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2014-2022, Global

12. Asia-Pacific Central Nervous System Drugs Market

12.1. Asia-Pacific Central Nervous System Drugs Market Overview

12.2. Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

12.3. Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

12.4. Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics

12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Asia-Pacific Countries

12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries

12.6. Asia-Pacific Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis

12.7.1. China Central Nervous System Drugs Market

12.7.1.1. China Central Nervous System Drugs Market Overview

12.7.1.2. China Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.1.3. China Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

12.7.1.4. China Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.2. Australia Central Nervous System Drugs Market

12.7.2.1. Australia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.2.2. Australia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

12.7.2.3. Australia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.3. Hong Kong Central Nervous System Drugs Market

12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.4. India Central Nervous System Drugs Market

12.7.4.1. India Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.4.2. India Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

12.7.4.3. India Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.5. Indonesia Central Nervous System Drugs Market

12.7.5.1. Indonesia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.6. Japan Central Nervous System Drugs Market

12.7.6.1. Japan Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.6.2. Japan Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

12.7.6.3. Japan Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.7. Malaysia Central Nervous System Drugs Market

12.7.7.1. Malaysia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.8. New Zealand Central Nervous System Drugs Market

12.7.8.1. New Zealand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.9. Philippines Central Nervous System Drugs Market

12.7.9.1. Philippines Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.10. Singapore Central Nervous System Drugs Market

12.7.10.1. Singapore Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.11. South Korea Central Nervous System Drugs Market

12.7.11.1. South Korea Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.12. Thailand Central Nervous System Drugs Market

12.7.12.1. Thailand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.13. Vietnam Central Nervous System Drugs Market

12.7.13.1. Vietnam Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13. Western Europe Central Nervous System Drugs Market

13.1. Western Europe Central Nervous System Drugs Market Overview

13.2. Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

13.3. Western Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

13.4. Western Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

13.5. Western Europe, Central Nervous System Drugs Market Metrics

13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Western Europe Countries

13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries

13.6. Western Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7. Western Europe Central Nervous System Drugs Market: Country Analysis

13.7.1. Austria Central Nervous System Drugs Market

13.7.1.1. Austria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.2. Belgium Central Nervous System Drugs Market

13.7.2.1. Belgium Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.3. Denmark Central Nervous System Drugs Market

13.7.3.1. Denmark Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.4. Finland Central Nervous System Drugs Market

13.7.4.1. Finland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.5. France Central Nervous System Drugs Market

13.7.5.1. France Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.5.2. France Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.5.3. France Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.6. Germany Central Nervous System Drugs Market

13.7.6.1. Germany Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.6.2. Germany Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.6.3. Germany Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.7. Ireland Central Nervous System Drugs Market

13.7.7.1. Ireland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.8. Italy Central Nervous System Drugs Market

13.7.8.1. Italy Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.8.2. Italy Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.8.3. Italy Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.9. Netherlands Central Nervous System Drugs Market

13.7.9.1. Netherlands Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.10. Norway Central Nervous System Drugs Market

13.7.10.1. Norway Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.11. Portugal Central Nervous System Drugs Market

13.7.11.1. Portugal Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.12. Spain Central Nervous System Drugs Market

13.7.12.1. Spain Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.12.2. Spain Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.12.3. Spain Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.13. Sweden Central Nervous System Drugs Market

13.7.13.1. Sweden Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.14. Switzerland Central Nervous System Drugs Market

13.7.14.1. Switzerland Central Nervous System Drugs Market2013-2022, Value (USD Billion)

13.7.15. UK Central Nervous System Drugs Market

13.7.15.1. UK Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.15.2. UK Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.15.3. UK Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

14. Eastern Europe Central Nervous System Drugs Market

14.1. Eastern Europe Central Nervous System Drugs Market Overview

14.2. Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

14.3. Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

14.4. Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

14.5. Eastern Europe, Central Nervous System Drugs Market Metrics

14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Eastern Europe Countries

14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries

14.6. Eastern Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis

14.7.1. Czech Republic Central Nervous System Drugs Market,

14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

14.7.2. Poland Central Nervous System Drugs Market

14.7.2.1. Poland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

14.7.3. Romania Central Nervous System Drugs Market

14.7.3.1. Romania Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

14.7.4. Russia Central Nervous System Drugs Market

14.7.4.1. Russia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

14.7.4.2. Russia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

14.7.4.3. Russia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

15. North America Central Nervous System Drugs Market

15.1. North America Central Nervous System Drugs Market Overview

15.2. North America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

15.3. North America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

15.4. North America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

15.5. North America, Central Nervous System Drugs Market Metrics

15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, North America Countries

15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries

15.6. North America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

15.7. North America Central Nervous System Drugs Market: Country Analysis

15.7.1. Canada Central Nervous System Drugs Market

15.7.1.1. Canada Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

15.7.2. Mexico Central Nervous System Drugs Market

15.7.2.1. Mexico Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

15.7.3. USA Central Nervous System Drugs Market

15.7.3.1. USA Central Nervous System Drugs Market Overview

15.7.3.2. USA Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

15.7.3.3. USA Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

15.7.3.4. USA Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16. South America Central Nervous System Drugs Market

16.1. South America Central Nervous System Drugs Market Overview

16.2. South America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

16.3. South America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

16.4. South America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

16.5. South America, Central Nervous System Drugs Market Metrics

16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, South America Countries

16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries

16.6. South America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16.7. South America Central Nervous System Drugs Market: Country Analysis

16.7.1. Argentina Central Nervous System Drugs Market

16.7.1.1. Argentina Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.2. Brazil Central Nervous System Drugs Market

16.7.2.1. Brazil Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.2.2. Brazil Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

16.7.2.3. Brazil Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16.7.3. Chile Central Nervous System Drugs Market

16.7.3.1. Chile Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.4. Colombia Central Nervous System Drugs Market

16.7.4.1. Colombia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.5. Peru Central Nervous System Drugs Market

16.7.5.1. Peru Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.6. Venezuela Central Nervous System Drugs Market

16.7.6.1. Venezuela Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

17. Middle East Central Nervous System Drugs Market

17.1. Middle East Central Nervous System Drugs Market Overview

17.2. Middle East, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

17.3. Middle East, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

17.4. Middle East, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

17.5. Middle East, Central Nervous System Drugs Market Metrics

17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Middle East Countries

17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries

17.6. Middle East Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

17.7. Middle East Central Nervous System Drugs Market: Country Analysis

17.7.1. Saudi Arabia Central Nervous System Drugs Market

17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

17.7.2. Israel Central Nervous System Drugs Market

17.7.2.1. Israel Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

17.7.3. Turkey Central Nervous System Drugs Market

17.7.3.1. Turkey Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

17.7.4. UAE Central Nervous System Drugs Market

17.7.4.1. UAE Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

18. Africa Central Nervous System Drugs Market

18.1. Africa Central Nervous System Drugs Market Overview

18.2. Africa, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

18.3. Africa, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

18.4. Africa, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

18.5. Africa, Central Nervous System Drugs Market Metrics

18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Africa Countries

18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries

18.6. Africa Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

18.7. Africa Central Nervous System Drugs Market: Country Analysis

18.7.1. Egypt Central Nervous System Drugs Market

18.7.1.1. Egypt Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

18.7.2. Nigeria Central Nervous System Drugs Market

18.7.2.1. Nigeria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

18.7.3. South Africa Central Nervous System Drugs Market

18.7.3.1. South Africa Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

19. Central Nervous System Drugs Market Competitive Landscape

19.1. Competitive Market Overview

19.2. Market Shares

19.3. Company Profiles

19.3.1. Biogen Inc

19.3.1.1. Company Overview

19.3.1.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.1.3. Company Central Nervous System Drugs Market Products And Services

19.3.1.4. Financial Performance

19.3.2. F. Hoffmann-La Roche Ltd

19.3.2.1. Company Overview

19.3.2.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.2.3. Company Central Nervous System Drugs Market Products And Services

19.3.2.4. Financial Performance

19.3.3. Johnson & Johnson

19.3.3.1. Company Overview

19.3.3.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.3.3. Company Central Nervous System Drugs Market Products And Services

19.3.3.4. Financial Performance

19.3.4. Pfizer Inc

19.3.4.1. Company Overview

19.3.4.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.4.3. Company Central Nervous System Drugs Market Products And Services

19.3.4.4. Financial Performance

19.3.5. Novartis AG

19.3.5.1. Company Overview

19.3.5.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.5.3. Company Central Nervous System Drugs Market Products And Services

19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

21. Market Background: Pharmaceutical Drugs Market

21.1. Pharmaceutical Drugs Market Characteristics

21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014-2022 Growth, by segment, Value (USD Billion), Global

21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

21.4. Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

21.5. Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

22. Recommendations

22.1. Global Central Nervous System Drugs Market In 2022- Growth Countries

22.2. Global Central Nervous System Drugs Market In 2022- Growth Segments

22.3. Global Central Nervous System Drugs Market In 2022- Growth Strategies

23. Appendix

23.1. NAICS Definitions Of Industry Covered In This Report

23.2. Abbreviations

23.3. Currencies

23.4. Research Inquiries

23.5. The Business Research Company

24. Copyright And Disclaimer


List Of Figure

Figure 1: Historic Market Growth, Value (USD Billion)

Figure 2: Forecast Market Growth, Value (USD Billion)

Figure 3: Global Central Nervous System Drugs Market, 2018, By Region, Value (USD Billion)

Figure 4: Global Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Region

Figure 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

Figure 6: Global Central Nervous System Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

Figure 7: Central Nervous System Drugs Market Size, Percentage Of GDP, 2014-2022, Global

Figure 8: Per Capita Average Central Nervous System Drugs Market Expenditure, 2014-2022, Global

Figure 9: Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 10: Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 11: Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 12: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Asia-Pacific Countries

Figure 13: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries

Figure 14: Asia-Pacific Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 15: China Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 16: China Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 17: China Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 18: Australia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 19: Australia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 20: Australia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 21: Hong Kong Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 22: India Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 23: India Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 24: India Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 25: Indonesia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 26: Japan Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 27: Japan Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 28: Japan Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 29: Malaysia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 30: New Zealand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 31: Philippines Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 32: Singapore Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 33: South Korea Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 34: Thailand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 35: Vietnam Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 36: Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 37: Western Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 38: Western Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 39: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Western Europe Countries

Figure 40: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries

Figure 41: Western Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 42: Austria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 43: Belgium Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 44: Denmark Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 45: Finland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 46: France Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 47: France Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 48: France Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 49: Germany Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 50: Germany Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 51: Germany Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 52: Ireland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 53: Italy Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 54: Italy Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 55: Italy Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 56: Netherlands Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 57: Norway Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 58: Portugal Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 59: Spain Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 60: Spain Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 61: Spain Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 62: Sweden Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 63: Switzerland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 64: UK Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 65: UK Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 66: UK Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 67: Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 68: Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 69: Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 70: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Eastern Europe Countries

Figure 71: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries

Figure 72: Eastern Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 73: Czech Republic Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 74: Poland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 75: Romania Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 76: Russia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 77: Russia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 78: Russia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 79: North America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 80: North America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 81: North America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 82: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, North America Countries

Figure 83: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries

Figure 84: North America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 85: Canada Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 86: Mexico Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 87: USA Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 88: USA Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 89: USA Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 90: South America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 91: South America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 92: South America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 93: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, South America Countries

Figure 94: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries

Figure 95: South America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 96: Argentina Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 97: Brazil Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 98: Brazil Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 99: Brazil Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 100: Chile Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 101: Colombia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 102: Peru Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 103: Venezuela Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 104: Middle East, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 105: Middle East, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 106: Middle East, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 107: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Middle East Countries

Figure 108: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries

Figure 109: Middle East Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 110: Saudi Arabia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 111: Israel Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 112: Turkey Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 113: UAE Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 114: Africa, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 115: Africa, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 116: Africa, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 117: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Africa Countries

Figure 118: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries

Figure 119: Africa Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 120: Egypt Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 121: Nigeria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 122: South Africa Central Nervous System Drugs Market2014-2022, Value (USD Billion)

Figure 123: Biogen Inc Financial Performance

Figure 124: F. Hoffmann-La Roche Ltd Financial Performance

Figure 125: Johnson & Johnson Financial Performance

Figure 126: Pfizer Inc Financial Performance

Figure 127: Novartis AG Financial Performance

Figure 128: Pharmaceutical Drugs Market Historic and Forecast, 2014-2022, Growth, By Segment, Value (USD Billion), Global

Figure 129: Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

Figure 130: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

Figure 131: Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 132: Global Central Nervous System Drugs Market In 2022- Growth Countries

Figure 133: Global Central Nervous System Drugs Market In 2022- Growth Segments

Figure 134: Global Central Nervous System Drugs Market In 2022- Growth Strategies


List Of Table

Table 1: Historic Market Growth, Value (USD Billion)

Table 2: Forecast Market Growth, Value (USD Billion)

Table 3: Global Central Nervous System Drugs Market, 2018, By Region, Value (USD Billion)

Table 4: Global Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Region

Table 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

Table 6: Global Central Nervous System Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

Table 7: Central Nervous System Drugs Market Size, Percentage Of GDP, 2014-2022, Global

Table 8: Per Capita Average Central Nervous System Drugs Market Expenditure, 2014-2022, Global

Table 9: Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 10: Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 11: Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 12: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Asia-Pacific Countries

Table 13: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries

Table 14: Asia-Pacific Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 15: China Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 16: China Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 17: China Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 18: Australia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 19: Australia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 20: Australia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 21: Hong Kong Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 22: India Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 23: India Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 24: India Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 25: Indonesia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 26: Japan Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 27: Japan Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 28: Japan Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 29: Malaysia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 30: New Zealand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 31: Philippines Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 32: Singapore Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 33: South Korea Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 34: Thailand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 35: Vietnam Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 36: Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 37: Western Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 38: Western Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 39: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Western Europe Countries

Table 40: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries

Table 41: Western Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 42: Austria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 43: Belgium Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 44: Denmark Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 45: Finland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 46: France Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 47: France Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 48: France Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 49: Germany Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 50: Germany Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 51: Germany Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 52: Ireland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 53: Italy Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 54: Italy Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 55: Italy Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 56: Netherlands Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 57: Norway Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 58: Portugal Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 59: Spain Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 60: Spain Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 61: Spain Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 62: Sweden Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 63: Switzerland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 64: UK Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 65: UK Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 66: UK Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 67: Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 68: Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 69: Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 70: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Eastern Europe Countries

Table 71: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries

Table 72: Eastern Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 73: Czech Republic Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 74: Poland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 75: Romania Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 76: Russia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 77: Russia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 78: Russia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 79: North America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 80: North America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 81: North America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 82: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, North America Countries

Table 83: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries

Table 84: North America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 85: Canada Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 86: Mexico Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 87: USA Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 88: USA Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 89: USA Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 90: South America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 91: South America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 92: South America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 93: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, South America Countries

Table 94: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries

Table 95: South America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 96: Argentina Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 97: Brazil Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 98: Brazil Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 99: Brazil Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 100: Chile Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 101: Colombia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 102: Peru Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 103: Venezuela Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 104: Middle East, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 105: Middle East, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 106: Middle East, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 107: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Middle East Countries

Table 108: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries

Table 109: Middle East Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 110: Saudi Arabia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 111: Israel Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 112: Turkey Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 113: UAE Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 114: Africa, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 115: Africa, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 116: Africa, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 117: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Africa Countries

Table 118: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries

Table 119: Africa Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 120: Egypt Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 121: Nigeria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 122: South Africa Central Nervous System Drugs Market2014-2022, Value (USD Billion)

Table 123: Biogen Inc Financial Performance

Table 124: F. Hoffmann-La Roche Ltd Financial Performance

Table 125: Johnson & Johnson Financial Performance

Table 126: Pfizer Inc Financial Performance

Table 127: Novartis AG Financial Performance

Table 128: Pharmaceutical Drugs Market Historic and Forecast, 2014-2022, Growth, By Segment, Value (USD Billion), Global

Table 129: Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

Table 130: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

Table 131: Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 132: Global Central Nervous System Drugs Market In 2022- Growth Countries

Table 133: Global Central Nervous System Drugs Market In 2022- Growth Segments

Table 134: Global Central Nervous System Drugs Market In 2022- Growth Strategies

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Nervous System Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs


Companies

Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG

North America was the largest region in the global central nervous system drugs market, accounting for 43% of the market in 2018. Asia Pacific was the second largest region accounting for 24% of the global central nervous system drugs market. Africa was the smallest region in the global central nervous system drugs market.

Pharmaceutical companies are partnering with technology companies and incorporating wearables in clinical studies and for research and development of CNS disease treatments. These wearable devices make use of sensors to detect early symptoms of Parkinson's disease such as tremors, slowness and stiffness in patients. Researchers use this data to gain insights about the disease and potential drug reactions, and thus reduce the time for trials by 30% to 50%. For instance, in 2017, Michael J. Fox Foundation for Parkinson's Research collaborated with specialty drugmaker Cynapsus Therapeutics and Intel to integrate wearable technology in a Phase-III clinical trial of APL-130277, an experimental drug for Parkinson's disease. Biogen, a leading CNS drugmaker is using Fitbit, a smart wearable tracker, to better understand multiple sclerosis in patient studies, and the technology is expected to extend in Alzheimer's disease research.

READ MORE

Scope

1. Executive Summary

2. Report Structure

3. Central Nervous System Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Central Nervous System Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Central Nervous System Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Central Nervous System Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Central Nervous System Drugs Market Trends And Strategies

8. Central Nervous System Drugs Market Size And Growth

8.1. Market Size

8.2. Historic Market Growth, Value (USD Billion)

8.2.1. Drivers Of The Market

8.2.2. Restraints On The Market

8.3. Forecast Market Growth, Value (USD Billion)

8.3.1. Drivers Of The Market

8.3.2. Restraints On The Market

9. Central Nervous System Drugs Market Regional Analysis

9.1. Global Central Nervous System Drugs Market, 2018, By Region, Value (USD Billion)

9.2. Global Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Region

9.3. Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

10. Central Nervous System Drugs Market Segmentation

10.1. Global Central Nervous System Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

10.1.1. Nervous System Drugs

10.1.2. Analgesics

10.1.3. Anti-Parkinson drugs

10.1.4. Anesthetics

10.1.5. Anti-Epileptics

10.1.6. Other CNS drugs

11. Central Nervous System Drugs Market Metrics

11.1. Central Nervous System Drugs Market Size, Percentage Of GDP, 2014-2022, Global

11.2. Per Capita Average Central Nervous System Drugs Market Expenditure, 2014-2022, Global

12. Asia-Pacific Central Nervous System Drugs Market

12.1. Asia-Pacific Central Nervous System Drugs Market Overview

12.2. Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

12.3. Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

12.4. Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

12.5. Asia-Pacific, Central Nervous System Drugs Market Metrics

12.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Asia-Pacific Countries

12.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries

12.6. Asia-Pacific Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7. Asia-Pacific Central Nervous System Drugs Market: Country Analysis

12.7.1. China Central Nervous System Drugs Market

12.7.1.1. China Central Nervous System Drugs Market Overview

12.7.1.2. China Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.1.3. China Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

12.7.1.4. China Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.2. Australia Central Nervous System Drugs Market

12.7.2.1. Australia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.2.2. Australia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

12.7.2.3. Australia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.3. Hong Kong Central Nervous System Drugs Market

12.7.3.1. Hong Kong Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.4. India Central Nervous System Drugs Market

12.7.4.1. India Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.4.2. India Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

12.7.4.3. India Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.5. Indonesia Central Nervous System Drugs Market

12.7.5.1. Indonesia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.6. Japan Central Nervous System Drugs Market

12.7.6.1. Japan Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.6.2. Japan Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

12.7.6.3. Japan Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

12.7.7. Malaysia Central Nervous System Drugs Market

12.7.7.1. Malaysia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.8. New Zealand Central Nervous System Drugs Market

12.7.8.1. New Zealand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.9. Philippines Central Nervous System Drugs Market

12.7.9.1. Philippines Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.10. Singapore Central Nervous System Drugs Market

12.7.10.1. Singapore Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.11. South Korea Central Nervous System Drugs Market

12.7.11.1. South Korea Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.12. Thailand Central Nervous System Drugs Market

12.7.12.1. Thailand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

12.7.13. Vietnam Central Nervous System Drugs Market

12.7.13.1. Vietnam Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13. Western Europe Central Nervous System Drugs Market

13.1. Western Europe Central Nervous System Drugs Market Overview

13.2. Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

13.3. Western Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

13.4. Western Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

13.5. Western Europe, Central Nervous System Drugs Market Metrics

13.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Western Europe Countries

13.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries

13.6. Western Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7. Western Europe Central Nervous System Drugs Market: Country Analysis

13.7.1. Austria Central Nervous System Drugs Market

13.7.1.1. Austria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.2. Belgium Central Nervous System Drugs Market

13.7.2.1. Belgium Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.3. Denmark Central Nervous System Drugs Market

13.7.3.1. Denmark Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.4. Finland Central Nervous System Drugs Market

13.7.4.1. Finland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.5. France Central Nervous System Drugs Market

13.7.5.1. France Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.5.2. France Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.5.3. France Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.6. Germany Central Nervous System Drugs Market

13.7.6.1. Germany Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.6.2. Germany Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.6.3. Germany Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.7. Ireland Central Nervous System Drugs Market

13.7.7.1. Ireland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.8. Italy Central Nervous System Drugs Market

13.7.8.1. Italy Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.8.2. Italy Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.8.3. Italy Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.9. Netherlands Central Nervous System Drugs Market

13.7.9.1. Netherlands Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.10. Norway Central Nervous System Drugs Market

13.7.10.1. Norway Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.11. Portugal Central Nervous System Drugs Market

13.7.11.1. Portugal Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.12. Spain Central Nervous System Drugs Market

13.7.12.1. Spain Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.12.2. Spain Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.12.3. Spain Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

13.7.13. Sweden Central Nervous System Drugs Market

13.7.13.1. Sweden Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.14. Switzerland Central Nervous System Drugs Market

13.7.14.1. Switzerland Central Nervous System Drugs Market2013-2022, Value (USD Billion)

13.7.15. UK Central Nervous System Drugs Market

13.7.15.1. UK Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

13.7.15.2. UK Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

13.7.15.3. UK Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

14. Eastern Europe Central Nervous System Drugs Market

14.1. Eastern Europe Central Nervous System Drugs Market Overview

14.2. Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

14.3. Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

14.4. Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

14.5. Eastern Europe, Central Nervous System Drugs Market Metrics

14.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Eastern Europe Countries

14.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries

14.6. Eastern Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

14.7. Eastern Europe Central Nervous System Drugs Market: Country Analysis

14.7.1. Czech Republic Central Nervous System Drugs Market,

14.7.1.1. Czech Republic Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

14.7.2. Poland Central Nervous System Drugs Market

14.7.2.1. Poland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

14.7.3. Romania Central Nervous System Drugs Market

14.7.3.1. Romania Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

14.7.4. Russia Central Nervous System Drugs Market

14.7.4.1. Russia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

14.7.4.2. Russia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

14.7.4.3. Russia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

15. North America Central Nervous System Drugs Market

15.1. North America Central Nervous System Drugs Market Overview

15.2. North America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

15.3. North America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

15.4. North America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

15.5. North America, Central Nervous System Drugs Market Metrics

15.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, North America Countries

15.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries

15.6. North America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

15.7. North America Central Nervous System Drugs Market: Country Analysis

15.7.1. Canada Central Nervous System Drugs Market

15.7.1.1. Canada Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

15.7.2. Mexico Central Nervous System Drugs Market

15.7.2.1. Mexico Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

15.7.3. USA Central Nervous System Drugs Market

15.7.3.1. USA Central Nervous System Drugs Market Overview

15.7.3.2. USA Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

15.7.3.3. USA Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

15.7.3.4. USA Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16. South America Central Nervous System Drugs Market

16.1. South America Central Nervous System Drugs Market Overview

16.2. South America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

16.3. South America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

16.4. South America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

16.5. South America, Central Nervous System Drugs Market Metrics

16.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, South America Countries

16.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries

16.6. South America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16.7. South America Central Nervous System Drugs Market: Country Analysis

16.7.1. Argentina Central Nervous System Drugs Market

16.7.1.1. Argentina Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.2. Brazil Central Nervous System Drugs Market

16.7.2.1. Brazil Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.2.2. Brazil Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

16.7.2.3. Brazil Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

16.7.3. Chile Central Nervous System Drugs Market

16.7.3.1. Chile Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.4. Colombia Central Nervous System Drugs Market

16.7.4.1. Colombia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.5. Peru Central Nervous System Drugs Market

16.7.5.1. Peru Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

16.7.6. Venezuela Central Nervous System Drugs Market

16.7.6.1. Venezuela Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

17. Middle East Central Nervous System Drugs Market

17.1. Middle East Central Nervous System Drugs Market Overview

17.2. Middle East, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

17.3. Middle East, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

17.4. Middle East, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

17.5. Middle East, Central Nervous System Drugs Market Metrics

17.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Middle East Countries

17.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries

17.6. Middle East Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

17.7. Middle East Central Nervous System Drugs Market: Country Analysis

17.7.1. Saudi Arabia Central Nervous System Drugs Market

17.7.1.1. Saudi Arabia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

17.7.2. Israel Central Nervous System Drugs Market

17.7.2.1. Israel Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

17.7.3. Turkey Central Nervous System Drugs Market

17.7.3.1. Turkey Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

17.7.4. UAE Central Nervous System Drugs Market

17.7.4.1. UAE Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

18. Africa Central Nervous System Drugs Market

18.1. Africa Central Nervous System Drugs Market Overview

18.2. Africa, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

18.3. Africa, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

18.4. Africa, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

18.5. Africa, Central Nervous System Drugs Market Metrics

18.5.1. Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Africa Countries

18.5.2. Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries

18.6. Africa Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

18.7. Africa Central Nervous System Drugs Market: Country Analysis

18.7.1. Egypt Central Nervous System Drugs Market

18.7.1.1. Egypt Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

18.7.2. Nigeria Central Nervous System Drugs Market

18.7.2.1. Nigeria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

18.7.3. South Africa Central Nervous System Drugs Market

18.7.3.1. South Africa Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

19. Central Nervous System Drugs Market Competitive Landscape

19.1. Competitive Market Overview

19.2. Market Shares

19.3. Company Profiles

19.3.1. Biogen Inc

19.3.1.1. Company Overview

19.3.1.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.1.3. Company Central Nervous System Drugs Market Products And Services

19.3.1.4. Financial Performance

19.3.2. F. Hoffmann-La Roche Ltd

19.3.2.1. Company Overview

19.3.2.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.2.3. Company Central Nervous System Drugs Market Products And Services

19.3.2.4. Financial Performance

19.3.3. Johnson & Johnson

19.3.3.1. Company Overview

19.3.3.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.3.3. Company Central Nervous System Drugs Market Products And Services

19.3.3.4. Financial Performance

19.3.4. Pfizer Inc

19.3.4.1. Company Overview

19.3.4.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.4.3. Company Central Nervous System Drugs Market Products And Services

19.3.4.4. Financial Performance

19.3.5. Novartis AG

19.3.5.1. Company Overview

19.3.5.2. Company Central Nervous System Drugs Market Structure And Strategy

19.3.5.3. Company Central Nervous System Drugs Market Products And Services

19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market

21. Market Background: Pharmaceutical Drugs Market

21.1. Pharmaceutical Drugs Market Characteristics

21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014-2022 Growth, by segment, Value (USD Billion), Global

21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

21.4. Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

21.5. Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

22. Recommendations

22.1. Global Central Nervous System Drugs Market In 2022- Growth Countries

22.2. Global Central Nervous System Drugs Market In 2022- Growth Segments

22.3. Global Central Nervous System Drugs Market In 2022- Growth Strategies

23. Appendix

23.1. NAICS Definitions Of Industry Covered In This Report

23.2. Abbreviations

23.3. Currencies

23.4. Research Inquiries

23.5. The Business Research Company

24. Copyright And Disclaimer


List Of Figure

Figure 1: Historic Market Growth, Value (USD Billion)

Figure 2: Forecast Market Growth, Value (USD Billion)

Figure 3: Global Central Nervous System Drugs Market, 2018, By Region, Value (USD Billion)

Figure 4: Global Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Region

Figure 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

Figure 6: Global Central Nervous System Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

Figure 7: Central Nervous System Drugs Market Size, Percentage Of GDP, 2014-2022, Global

Figure 8: Per Capita Average Central Nervous System Drugs Market Expenditure, 2014-2022, Global

Figure 9: Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 10: Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 11: Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 12: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Asia-Pacific Countries

Figure 13: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries

Figure 14: Asia-Pacific Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 15: China Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 16: China Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 17: China Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 18: Australia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 19: Australia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 20: Australia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 21: Hong Kong Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 22: India Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 23: India Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 24: India Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 25: Indonesia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 26: Japan Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 27: Japan Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 28: Japan Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 29: Malaysia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 30: New Zealand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 31: Philippines Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 32: Singapore Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 33: South Korea Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 34: Thailand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 35: Vietnam Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 36: Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 37: Western Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 38: Western Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 39: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Western Europe Countries

Figure 40: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries

Figure 41: Western Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 42: Austria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 43: Belgium Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 44: Denmark Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 45: Finland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 46: France Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 47: France Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 48: France Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 49: Germany Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 50: Germany Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 51: Germany Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 52: Ireland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 53: Italy Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 54: Italy Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 55: Italy Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 56: Netherlands Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 57: Norway Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 58: Portugal Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 59: Spain Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 60: Spain Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 61: Spain Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 62: Sweden Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 63: Switzerland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 64: UK Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 65: UK Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 66: UK Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 67: Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 68: Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 69: Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 70: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Eastern Europe Countries

Figure 71: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries

Figure 72: Eastern Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 73: Czech Republic Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 74: Poland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 75: Romania Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 76: Russia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 77: Russia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 78: Russia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 79: North America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 80: North America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 81: North America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 82: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, North America Countries

Figure 83: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries

Figure 84: North America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 85: Canada Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 86: Mexico Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 87: USA Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 88: USA Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 89: USA Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 90: South America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 91: South America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 92: South America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 93: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, South America Countries

Figure 94: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries

Figure 95: South America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 96: Argentina Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 97: Brazil Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 98: Brazil Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Figure 99: Brazil Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 100: Chile Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 101: Colombia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 102: Peru Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 103: Venezuela Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 104: Middle East, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 105: Middle East, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 106: Middle East, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 107: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Middle East Countries

Figure 108: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries

Figure 109: Middle East Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 110: Saudi Arabia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 111: Israel Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 112: Turkey Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 113: UAE Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 114: Africa, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Figure 115: Africa, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Figure 116: Africa, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Figure 117: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Africa Countries

Figure 118: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries

Figure 119: Africa Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 120: Egypt Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 121: Nigeria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Figure 122: South Africa Central Nervous System Drugs Market2014-2022, Value (USD Billion)

Figure 123: Biogen Inc Financial Performance

Figure 124: F. Hoffmann-La Roche Ltd Financial Performance

Figure 125: Johnson & Johnson Financial Performance

Figure 126: Pfizer Inc Financial Performance

Figure 127: Novartis AG Financial Performance

Figure 128: Pharmaceutical Drugs Market Historic and Forecast, 2014-2022, Growth, By Segment, Value (USD Billion), Global

Figure 129: Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

Figure 130: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

Figure 131: Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Figure 132: Global Central Nervous System Drugs Market In 2022- Growth Countries

Figure 133: Global Central Nervous System Drugs Market In 2022- Growth Segments

Figure 134: Global Central Nervous System Drugs Market In 2022- Growth Strategies


List Of Table

Table 1: Historic Market Growth, Value (USD Billion)

Table 2: Forecast Market Growth, Value (USD Billion)

Table 3: Global Central Nervous System Drugs Market, 2018, By Region, Value (USD Billion)

Table 4: Global Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Region

Table 5: Global Central Nervous System Drugs Market, Growth And Market Share Comparison, By Region

Table 6: Global Central Nervous System Drugs Market, Segmentation By Type, 2014-2022, Value (USD Billion)

Table 7: Central Nervous System Drugs Market Size, Percentage Of GDP, 2014-2022, Global

Table 8: Per Capita Average Central Nervous System Drugs Market Expenditure, 2014-2022, Global

Table 9: Asia-Pacific, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 10: Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 11: Asia-Pacific, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 12: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Asia-Pacific Countries

Table 13: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Asia-Pacific Countries

Table 14: Asia-Pacific Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 15: China Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 16: China Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 17: China Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 18: Australia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 19: Australia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 20: Australia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 21: Hong Kong Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 22: India Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 23: India Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 24: India Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 25: Indonesia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 26: Japan Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 27: Japan Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 28: Japan Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 29: Malaysia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 30: New Zealand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 31: Philippines Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 32: Singapore Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 33: South Korea Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 34: Thailand Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 35: Vietnam Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 36: Western Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 37: Western Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 38: Western Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 39: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Western Europe Countries

Table 40: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Western Europe Countries

Table 41: Western Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 42: Austria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 43: Belgium Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 44: Denmark Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 45: Finland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 46: France Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 47: France Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 48: France Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 49: Germany Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 50: Germany Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 51: Germany Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 52: Ireland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 53: Italy Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 54: Italy Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 55: Italy Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 56: Netherlands Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 57: Norway Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 58: Portugal Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 59: Spain Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 60: Spain Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 61: Spain Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 62: Sweden Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 63: Switzerland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 64: UK Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 65: UK Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 66: UK Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 67: Eastern Europe, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 68: Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 69: Eastern Europe, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 70: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Eastern Europe Countries

Table 71: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Eastern Europe Countries

Table 72: Eastern Europe Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 73: Czech Republic Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 74: Poland Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 75: Romania Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 76: Russia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 77: Russia Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 78: Russia Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 79: North America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 80: North America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 81: North America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 82: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, North America Countries

Table 83: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, North America Countries

Table 84: North America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 85: Canada Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 86: Mexico Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 87: USA Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 88: USA Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 89: USA Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 90: South America, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 91: South America, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 92: South America, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 93: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, South America Countries

Table 94: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, South America Countries

Table 95: South America Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 96: Argentina Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 97: Brazil Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 98: Brazil Central Nervous System Drugs Market, 2014-2022, Volume (Million Units)

Table 99: Brazil Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 100: Chile Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 101: Colombia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 102: Peru Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 103: Venezuela Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 104: Middle East, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 105: Middle East, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 106: Middle East, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 107: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Middle East Countries

Table 108: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Middle East Countries

Table 109: Middle East Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 110: Saudi Arabia Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 111: Israel Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 112: Turkey Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 113: UAE Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 114: Africa, Central Nervous System Drugs Market, 2018, By Country, Value (USD Billion)

Table 115: Africa, Central Nervous System Drugs Market, 2014-2022, Historic And Forecast, By Country

Table 116: Africa, Central Nervous System Drugs Market, 2014-2022, Growth And Market Share Comparison, By Country

Table 117: Per Capita Average Central Nervous System Drugs Expenditure, 2014-2022, Africa Countries

Table 118: Parkinson Prevalence Rate, Central Nervous System Drugs Market, Central Nervous System Drugs Market/Parkinson Prevalence Rate, 2018, Africa Countries

Table 119: Africa Central Nervous System Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 120: Egypt Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 121: Nigeria Central Nervous System Drugs Market, 2014-2022, Value (USD Billion)

Table 122: South Africa Central Nervous System Drugs Market2014-2022, Value (USD Billion)

Table 123: Biogen Inc Financial Performance

Table 124: F. Hoffmann-La Roche Ltd Financial Performance

Table 125: Johnson & Johnson Financial Performance

Table 126: Pfizer Inc Financial Performance

Table 127: Novartis AG Financial Performance

Table 128: Pharmaceutical Drugs Market Historic and Forecast, 2014-2022, Growth, By Segment, Value (USD Billion), Global

Table 129: Global Pharmaceutical Drugs Market, 2018, By Region, Value (USD Billion)

Table 130: Global Pharmaceutical Drugs Market, 2014-2022, Historic And Forecast, By Region

Table 131: Global Pharmaceutical Drugs Market, 2014-2022, Segmentation By Type, Value (USD Billion)

Table 132: Global Central Nervous System Drugs Market In 2022- Growth Countries

Table 133: Global Central Nervous System Drugs Market In 2022- Growth Segments

Table 134: Global Central Nervous System Drugs Market In 2022- Growth Strategies

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Nervous System Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs


Companies

Biogen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Pfizer Inc, Novartis AG